October 13, 2008

TB Alliance Enters into Collaboration with sanofi-aventis to Fight Tuberculosis

Goal is to Accelerate Development of Drugs Against Tuberculosis
October 9, 2008

Global Alliance for TB Drug Development Appoints Respected Scientist and Director of R&D as New Chief Executive

Dr. Melvin Spigelman, TB Alliance Director of Research and Development, to Lead Organization in Speeding Search for Faster, Better Cure
August 26, 2008

TB Alliance Appoints First Chief Administrative Officer

Healthcare Executive Colleen Pero to Guide Growth of World’s Leading TB Drug Development Organization
June 23, 2008

Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development Announce Five-Year Collaboration Targeted to Accelerate TB Treatment R&D

The NITD and the TB Alliance’s collaboration aims to move projects quickly from the research phase through the translational stage and into development

Pages